United Asset Strategies Inc. Acquires 5,205 Shares of The Clorox Company $CLX

Posted by Brian Himes on Jul 8th, 2026

United Asset Strategies Inc. raised its stake in shares of The Clorox Company (NYSE:CLX – Free Report) by 243.0% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 7,347 shares of the company’s stock after purchasing an additional 5,205 shares during the period. United Asset Strategies Inc.’s holdings in Clorox were worth $761,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Vermillion & White Wealth Management Group LLC bought a new position in shares of Clorox during the third quarter worth about $25,000. Caitlin John LLC raised its holdings in Clorox by 1,807.1% during the 4th quarter. Caitlin John LLC now owns 267 shares of the company’s stock worth $27,000 after purchasing an additional 253 shares during the last quarter. Darwin Wealth Management LLC bought a new position in Clorox during the 2nd quarter worth approximately $29,000. Vision Financial Markets LLC lifted its position in shares of Clorox by 166.7% in the 4th quarter. Vision Financial Markets LLC now owns 320 shares of the company’s stock worth $32,000 after purchasing an additional 200 shares during the period. Finally, Root Financial Partners LLC lifted its position in shares of Clorox by 83.8% in the 1st quarter. Root Financial Partners LLC now owns 318 shares of the company’s stock worth $33,000 after purchasing an additional 145 shares during the period. 78.53% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Clorox

In related news, Director Pierre R. Breber acquired 5,000 shares of the stock in a transaction on Tuesday, May 5th. The shares were acquired at an average price of $85.82 per share, with a total value of $429,100.00. Following the completion of the transaction, the director owned 18,000 shares in the company, valued at approximately $1,544,760. The trade was a 38.46% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link. 0.63% of the stock is owned by insiders.

Clorox Trading Up 0.2%

NYSE:CLX opened at $97.45 on Wednesday. The company has a debt-to-equity ratio of 27.03, a current ratio of 0.84 and a quick ratio of 0.65. The Clorox Company has a one year low of $84.70 and a one year high of $132.03. The company has a market cap of $11.78 billion, a PE ratio of 15.82, a PEG ratio of 0.46 and a beta of 0.54. The firm has a 50-day moving average of $94.19 and a 200-day moving average of $104.20.

Clorox (NYSE:CLX – Get Free Report) last announced its quarterly earnings results on Thursday, April 30th. The company reported $1.64 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.55 by $0.09. The business had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.67 billion. Clorox had a return on equity of 443.64% and a net margin of 11.18%.Clorox’s revenue was up .1% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.45 earnings per share. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. As a group, equities research analysts expect that The Clorox Company will post 5.61 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on CLX shares. Morgan Stanley dropped their target price on shares of Clorox from $110.00 to $97.00 and set an “equal weight” rating on the stock in a report on Friday, May 1st. Jefferies Financial Group lowered their price objective on Clorox from $139.00 to $125.00 and set a “buy” rating for the company in a research report on Monday, May 4th. TD Cowen lifted their price objective on Clorox from $98.00 to $111.00 and gave the stock a “hold” rating in a research report on Tuesday, March 31st. BNP Paribas Exane dropped their price objective on Clorox from $128.00 to $97.00 and set a “neutral” rating on the stock in a research note on Tuesday, May 12th. Finally, The Goldman Sachs Group reaffirmed a “sell” rating and set a $83.00 target price on shares of Clorox in a research note on Friday, May 1st. One equities research analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and five have given a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Reduce” and a consensus target price of $103.40.

View Our Latest Research Report on CLX

Clorox Company Profile

(Free Report)

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.